Ardelyx, Inc.
USD5.09
+0.00 (+0.00%)
CEO
Michael G. Raab
IPO Date
2014-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.08
Prev. Close
$5.09
Day Low
$4.98
Day High
$5.12
52W Low
$4.08
52W High
$8.40
Market Cap
$1.26B
Volume
3.77M
| 41,668 |
| $5.06 |
| 17 Jul 2026 | RAAB MICHAEL | director, officer: President & CEO | M-Exempt | Disposed | 20,834 | $0.99 |
| 22 Jun 2026 | Williams Laura A | Chief Patient Officer | M-Exempt | Acquired | 31,000 | $0.99 |
| 22 Jun 2026 | Williams Laura A | Chief Patient Officer | S-Sale | Disposed | 81,898 | $5.99 |
| 22 Jun 2026 | Williams Laura A | Chief Patient Officer | M-Exempt | Disposed | 31,000 | $0.99 |
| 18 Jun 2026 | Parsey Merdad | director | A-Award | Acquired | 26,455 | $0.00 |
| 18 Jun 2026 | Parsey Merdad | director | A-Award | Acquired | 39,715 | $5.67 |
| 18 Jun 2026 | Rodgers Richard J | director | A-Award | Acquired | 26,455 | $0.00 |
| 18 Jun 2026 | Rodgers Richard J | director | A-Award | Acquired | 39,715 | $5.67 |